Efficacy and toxicity of re-irradiation for esophageal cancer patients with locoregional recurrence: a retrospective analysis

[1] Bray F(2018)Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries CA:A Cancer J Clin 68 394-424

[2] Ferlay J(2005)Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus J Clin Oncol 23 2310-2317

[3] Soerjomataram I(2016)Patterns of recurrence in early-stage oesophageal cancer after chemoradiotherapy and surgery compared with surgery alone Br J Surg 103 117-125

[4] Siegel RL(2015)Prognostic factors, patterns of recurrence and toxicity for patients with esophageal cancer undergoing definitive radiotherapy or chemo-radiotherapy J Radiat Res 56 742-749

[5] Torre LA(2015)Radio(chemo)therapy for locally advanced squamous cell carcinoma of the esophagus: long-term outcome Strahlentherapie Onkologie Organ der Deutschen Rontgengesellschaft 191 153-160

[6] Jemal A(2007)Radiation therapy for recurrent esophageal cancer after surgery: clinical results and prognostic factors Jpn J Clin Oncol 37 918-923

[7] Stahl M(2012)Reirradiation with cetuximab in locoregional recurrent and inoperable squamous cell carcinoma of the head and neck: feasibility and first efficacy results Int J Radiat Oncol Biol Phys 83 e377-e383

[8] Stuschke M(2017)Current status and future prospects for esophageal cancer treatment Ann Thor Cardiovasc Surg 23 1-11

[9] Lehmann N(2008)Comparative evaluation between re-irradiation and demand endoscopic dilatation vs. endoscopic dilatation alone in patients with recurrent/reactivated residual in-field esophageal malignancies J Cancer Res Ther 4 121-125

[10] Meyer H-J(2011)Multimodal approaches including three-dimensional conformal re-irradiation for recurrent or persistent esophageal cancer: preliminary results J Radiat Res 52 812-820

[1] Bray F(2018)Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries CA:A Cancer J Clin 68 394-424

[2] Ferlay J(2005)Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus J Clin Oncol 23 2310-2317

[3] Soerjomataram I(2016)Patterns of recurrence in early-stage oesophageal cancer after chemoradiotherapy and surgery compared with surgery alone Br J Surg 103 117-125

[4] Siegel RL(2015)Prognostic factors, patterns of recurrence and toxicity for patients with esophageal cancer undergoing definitive radiotherapy or chemo-radiotherapy J Radiat Res 56 742-749

[5] Torre LA(2015)Radio(chemo)therapy for locally advanced squamous cell carcinoma of the esophagus: long-term outcome Strahlentherapie Onkologie Organ der Deutschen Rontgengesellschaft 191 153-160

[6] Jemal A(2007)Radiation therapy for recurrent esophageal cancer after surgery: clinical results and prognostic factors Jpn J Clin Oncol 37 918-923

[7] Stahl M(2012)Reirradiation with cetuximab in locoregional recurrent and inoperable squamous cell carcinoma of the head and neck: feasibility and first efficacy results Int J Radiat Oncol Biol Phys 83 e377-e383

[8] Stuschke M(2017)Current status and future prospects for esophageal cancer treatment Ann Thor Cardiovasc Surg 23 1-11

[9] Lehmann N(2008)Comparative evaluation between re-irradiation and demand endoscopic dilatation vs. endoscopic dilatation alone in patients with recurrent/reactivated residual in-field esophageal malignancies J Cancer Res Ther 4 121-125

[10] Meyer H-J(2011)Multimodal approaches including three-dimensional conformal re-irradiation for recurrent or persistent esophageal cancer: preliminary results J Radiat Res 52 812-820